![Osamu Nureki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 447 002 $ al 31/05/2026
Osamu Nureki is the founder of Modalis Therapeutics Corp., which was founded in 2016.
He holds the title of Outside Director at the company.
He is currently working as an Outside Director at Curreio, Inc. since 2019 and as a Professor at the University of Tokyo since 2008.
Dr. Nureki completed his undergraduate and graduate degrees at the University of Tokyo.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 1.581.300 ( 1,64 % ) | 447 002 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MODALIS THERAPEUTICS CORPORATION | Fundador | 01/01/2016 |
Curreio, Inc.
 Curreio, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Director/Miembro de la Junta | 01/11/2019 |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/04/2008 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Tokyo
University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modalis Therapeutics Corp.
 Modalis Therapeutics Corp. BiotechnologyHealth Technology Develops transformative therapeutics for diseases which are caused by malfunctioning of genes | Health Technology |
Curreio, Inc.
Curreio, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
